Management
A team shaped by research, diagnostics, and long practice
CEO and Co-founder
Håkon Sæterøy
With +30 years of experience in management, corporate finance and business development, Sæterøy has developed an extensive international network within the life science industry and investor communities. He has broad experience from board positions and investments in several Norwegian companies, including being longstanding executive chairman of IC Targets AS, DiaGenic ASA and Serodus ASA. Before engaging in life science companies, he worked 15 years in investment banking companies. He has previously served as chairman of the board of Nansen Neuroscience Network and as a board member of Oslo Cancer Cluster. Sæterøy is “siviløkonom” from NHH (Norwegian School of Economics), Bergen – a 4 year programme in economics and business administration consisting of three years at bachelor level and one year at master level.
CMO and Co-founder
Erik Christensen
Christensen has 30+ years of experience from the diagnostics industry, including as CEO of diagnostic company DiaGenic ASA, as Nordic Medical Director subsequently as Country Manager for Abbott’s Diagnostic division in Norway. He has extensive experience from clinical practice, serving as senior consultant in Clinical Chemistry at Rikshospitalet and Ullevål University Hospital, holds a medical degree from Odense University, and earned his PhD peroxisomal ß-oxidation of fatty acids from the University of Oslo. He is a certified Clinical Pathologists by the Norwegian Medical Association and is a longstanding advisor to the Norwegian Research Council.
Laboratory Director
Line Amundsen
Line holds a master`s degree in chemistry from the University of Bergen. She has many years of experience from working in an ISO-certified clinical laboratory at Haukeland University Hospital in Oslo in addition to several years working in the industry. She has wide experience in developing and validating robust immunoassays for clinical use.
